Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Comment by Lowfloatmining1on Jan 11, 2021 5:33pm
91 Views
Post# 32272244

RE:RE:RE:Whats Expected .

RE:RE:RE:Whats Expected .

I agree with you those are positives  when the store are actually turning a profit. Unfortunately all those scenarios you mentioned are at the expense of current shareholders.  What I mean is the company has to issue shares which more often then not end up diluting anyone holding now.  

This is the problem a lot of cannabis companies had and shareholders were diluted so much.  The end result was multiple store closures because the demand simply was not there and this is an even more niche market.  

What I'm saying is buzz should be proving itself with actual sales instead of expanding at the expense shareholders. Just because they are opening more stores doesn't mean more sales. This has been proven.  


Fishercat1 wrote: Takes money to make money and expension creates more sales as more stores and more revs and anybody can see thats a good thing. 1 STORE, 4 STORES, 10 STORES ?? . Right Flagship store  so more revs and exposure , On line sales so more revs and exposure online . Yah , works for me . 

 

<< Previous
Bullboard Posts
Next >>